16/07/2025
Fibroscan is a non-invasive tool to assess and monitor patients with liver disease.
Schedule your FibroScan.
Text 0968-8521-992 for inquiries and appointments.
See you at Metro Bacolod Hospital and Medical Center.
⚠️ Metabolic dysfunction-associated steatotic liver disease (MASLD), commonly called “fatty liver disease,” is more than a liver condition—it’s a warning sign that is often overlooked in patients with obesity, prediabetes, and type 2 diabetes (T2D).
Unlike hepatitis, MASLD is metabolic in nature. It frequently coexists with obesity, T2D, and cardiovascular disease, yet is rarely part of the conversation.
Here’s why it should be:
➡️ 38% of adults are affected by MASLD worldwide
➡️ 65% or more of individuals with T2D have MASLD
➡️ Doubles the risk of heart attack or stroke
➡️ Triples the risk of developing diabetes
Fat accumulation in the liver isn’t just a downstream effect of metabolic dysfunction—it’s an active driver of it. Recognizing MASLD as part of metabolic dysfunction should transform cardiometabolic care and patient outcomes.
